Which DVT Patients Could Be Considered the Best Candidates for Home Therapy?

• References

• 1 Koopman MMW, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. et al Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight-heparin administered at home. N Engl J Med 1996; 334: 682-7.
• 2 Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Tur-pie AG, Demers C, Kovacs M. et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.
• 3 Lindmarker P, Holmström M. Use of a low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. J Intern Med 1996; 240: 395-401.
• 4 van den Belt AGM, Bossuy PMM, Prins MH, Gallus AS, Büller HR. for the TASMAN Study Group. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis. An economic evaluation. Thromb Haemost 1998; 79:: 259-63.
• 5 Monreal M, Lafoz E, Ruiz J, Callejas JM, Arias A. Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: A prospective study. Eur J Vasc Surg 1994; 8: 584-9.
• 6 Monreal M, Urrutia A, Martí S, Cuxart A, Roncalés J. Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy. Haemostasis 1997; 27: 91-8.